Alpha-defensin as a Diagnostic Means to Distinguish Between Acute Bacterial and Viral Infections
NCT03846921 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2019-03-08
Summary
This study aims to investigate the use of alpha-defensin as a diagnostic means to distinguish between acute bacterial and viral infections.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
Laboratory blood test
Laboratory blood test will be analyzed to determine whether there is a rise in alpha-defensin
Sponsors & Collaborators
-
Hillel Yaffe Medical Center
lead OTHER_GOV
Principal Investigators
-
Eias Kassem, MD · Hillel Yaffe Medical Center
Eligibility
- Min Age
- 1 Year
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-03-04
- Primary Completion
- 2020-03-31
- Completion
- 2020-03-31
Countries
- Israel
Study Locations
More Related Trials
-
Differential Diagnostics of Etiology of Acute Infections
NCT03161951 ·Status: COMPLETED
-
Genotypic Versus Phenotypic Susceptibility Testing of Positive Blood Cultures
NCT03744728 ·Status: UNKNOWN ·Phase: NA
-
Post-coronavirus Disease-2019 Fatigue
NCT04851561 ·Status: COMPLETED
-
Rapid Diagnostics for Upper Respiratory Infections in the Emergency Department
NCT02957136 ·Status: COMPLETED ·Phase: NA
-
Evaluating the Immune Response for COVID-19
NCT04348422 ·Status: COMPLETED
-
Predictors of COVID-19 Infection and Disease Progression
NCT04484597 ·Status: UNKNOWN
-
Assessement of Viral Shedding Duration After a Respiratory Tract Infection in Oncology and Hematology Patients
NCT03389997 ·Status: COMPLETED ·Phase: NA
-
The Natural History of Hospitalized COVID-19 Patients
NCT04424992 ·Status: RECRUITING
-
A Rapid Test for Acute Respiratory Illness
NCT03192072 ·Status: COMPLETED
-
Neutrophil Phenotypic Profiling and Surgical Site Infections in Surgical Patients
NCT04773457 ·Status: ACTIVE_NOT_RECRUITING
-
Establishing a Controlled Human Infection Model of Bordetella Pertussis
NCT05136599 ·Status: COMPLETED ·Phase: PHASE1
-
Detection of Bacterial and Viral Pathogens Infection Among Hospitalized Patients Feasibility Study
NCT05399615 ·Status: WITHDRAWN ·Phase: NA
-
Comparison of Cefdinir and Cefdinir/Clavulanic Acid Combination in Adults
NCT03400735 ·Status: UNKNOWN ·Phase: PHASE4
-
COVID-19: Investigation of Transmission and Immunisation Among Hospital Staff
NCT04346186 ·Status: COMPLETED
-
Evaluation of Inflammatory Cytokines During COVID-19
NCT04824495 ·Status: UNKNOWN
-
Rapid Assessment of and Prophylaxis for Influenza in Dwellers of Long-term Care Facilities
NCT02964871 ·Status: COMPLETED ·Phase: NA
-
Bacterial Assessment of Middle Ear Fluid in Children Undergoing Ventilation Tube Placement Surgery
NCT01157910 ·Status: UNKNOWN
-
Evaluating a Host-response Based Diagnostic for Distinguishing Between Bacterial and Viral Etiology in Patients With Lower Respiratory Tract Infection (LRTI)
NCT03011515 ·Status: COMPLETED
-
C-reactive Protein (CRP)-Guided Management Algorithm for Adults With Acute Cough
NCT00221351 ·Status: COMPLETED ·Phase: NA
-
An International Observational Study of Adults With Acute Infection
NCT07069400 ·Status: RECRUITING
-
Assessing Performance of the Testing Done Simple Covid 19 Antigen Test
NCT05610449 ·Status: COMPLETED
-
Risk Stratification With Chest CT to Rule-out Suspected SARS-CoV-2 Infections
NCT04357938 ·Status: COMPLETED
-
Sensitivity Evaluation of Serological Tests for Covid-19
NCT04678024 ·Status: UNKNOWN
-
Long-Term Experience and Health Effects of COVID-19
NCT04477902 ·Status: COMPLETED
-
Study of Leukocyte Immunophenotype and the Lipid Transport System as Predictive Biomarkers of Severe Bacterial Infections
NCT04178915 ·Status: ENROLLING_BY_INVITATION